Unity Biotechnology Inc Reports Results For The Quarter Ended In June: Earnings Summary

Unity Biotechnology

12/08/2022 13:14

* UNITY Biotechnology Inc  UBX.OQ  reported a quarterly
adjusted
loss of 19 cents​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 28 cents per share.
    * Revenue was $236.00 thousand​; analysts expected zero. 
    * UNITY Biotechnology Inc's reported EPS for the quarter was
a
loss of 19 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * UNITY Biotechnology Inc shares had risen by 50.9% this
quarter and lost 41.8% so far this year.
    * The company reported a quarterly loss of $13.14 million.
    * Wall Street's median 12-month price target for UNITY
Biotechnology Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 12
at 12:14 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.28          -0.19          Beat
 Mar. 31 2022      -0.26          -0.28          Missed
 Dec. 31 2021      -0.38          -0.18          Beat
 Sep. 30 2021      -0.37          -0.30          Beat